BreastTh2 CellsTh1 CellsTh17 CellsCarcinoma, Ductal, BreastBreast DiseasesBreast FeedingBreast Neoplasms, MaleReceptors, EstrogenMammographyFibrocystic Breast DiseaseCell Line, TumorBreast ImplantsReceptor, erbB-2Breast Self-ExaminationReceptors, ProgesteroneTamoxifenGene Expression Regulation, NeoplasticCarcinoma, Intraductal, NoninfiltratingMastectomyPrognosisCarcinoma, LobularTumor Markers, BiologicalNeoplasm InvasivenessUltrasonography, MammaryNeoplasm MetastasisGenes, BRCA1Antineoplastic Agents, HormonalRisk FactorsCase-Control StudiesLymphatic MetastasisNeoplasm StagingImmunohistochemistryPostmenopauseTumor Cells, CulturedMilk, HumanMastectomy, SegmentalMammaplastyBreast CystCarcinomaNeoplasm ProteinsChemotherapy, AdjuvantMCF-7 CellsMammary Glands, HumanEstrogen Receptor alphaFibroadenomaAntineoplastic AgentsEstrogensNipplesTh1-Th2 BalancePremenopauseMammary Neoplasms, ExperimentalCell ProliferationBreast ImplantationMenopauseBRCA2 ProteinBRCA1 ProteinAxillaGenes, BRCA2Neoplasms, Hormone-DependentTime FactorsTriple Negative Breast NeoplasmsInflammatory Breast NeoplasmsGenes, erbB-2Carcinoma, DuctalRNA, MessengerGenetic Predisposition to DiseaseAromatase InhibitorsEstrogen AntagonistsGene Expression ProfilingNeoplasm Recurrence, LocalDisease-Free SurvivalCarcinoma in SituFollow-Up StudiesSurvival AnalysisTreatment OutcomeMice, NudeReverse Transcriptase Polymerase Chain ReactionMass ScreeningSignal TransductionCohort StudiesIncidenceAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmAge FactorsProspective StudiesEstradiolRiskRetrospective StudiesBiopsy, NeedleSensitivity and SpecificityRisk AssessmentLymph NodesMastectomy, Modified RadicalDNA, NeoplasmApoptosisSurvival RateMice, Inbred BALB COdds RatioSelective Estrogen Receptor Modulators